Curon gets more time to meeting Nasdaq listing standards

New York, Nov. 29 - Curon Medical, Inc. said it has been given another six months to meet Nasdaq's listing standards.

As a result, the company's stock will remain listed until May 11, 2006. During that period, the closing bid price will have to remain at $1.00 or higher for at least 10 consecutive trading days to avoid delisting.

Curon noted that its stockholders have approved up to a one-for-four reverse stock split, a move that the company is retaining as an option to ensure compliance.

Filing the 10-Q report for the third quarter on Nov. 10 brought the company into line with Nasdaq's standards for reporting financial results.

Curon is a Fremont, Calif. maker of products for the treatment of gastrointestinal disorders.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.